Status:

TERMINATED

In Vivo Alzheimer Proteomics

Lead Sponsor:

University Hospital, Montpellier

Collaborating Sponsors:

Assistance Publique - Hôpitaux de Paris

University Hospital, Clermont-Ferrand

Conditions:

Probable Alzheimer Disease

Parkinson Disease

Eligibility:

All Genders

55-85 years

Phase:

NA

Brief Summary

In France, an estimated 860 000 patients are affected by Alzheimer Disease (AD) which represents, as in other developed countries, a major public health issue. In many cases, AD diagnosis is uncertain...

Eligibility Criteria

Inclusion

  • Reports written consent, informed and signed by the patient and a trusted person
  • Subject member or beneficiary of a social security system
  • Specific criteria for group 1 and 2B :
  • Age between 55 and 85 years old for patients
  • Subject with AD or other neurodegenerative disease (frontotemporal dementia, dementia with Lewy bodies, Parkinson disease)
  • Subjects with chronic adult hydrocephalus (HCA) requiring depletion lumbar puncture (PL)
  • Specific criteria for group 2A :
  • \- Adult patient requiring neurosurgery with CSF shunt (subject with brain trauma, acute hydrocephaly) and favorable evolution that allows removal of the shunt

Exclusion

  • Patient deprived of liberty by judicial or administrative decision
  • Major protected by law
  • Pregnancy, women of childbearing age with risk of pregnancy, or breast-feeding
  • Presence of a transmissible viral disease (HlV, hepatitis B and C)
  • Patient included in a clinical trial
  • lnadequate cardiac, hepatic or severe renal disfunction
  • Disease amino acid metabolism (Leucinose..)

Key Trial Info

Start Date :

October 8 2013

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

May 22 2018

Estimated Enrollment :

89 Patients enrolled

Trial Details

Trial ID

NCT02263235

Start Date

October 8 2013

End Date

May 22 2018

Last Update

December 28 2021

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Laboratoire de Biochimie et Protéomique Clinique, CHU Montpellier

Montpellier, France, 34295